Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Case report: Pregnancy and birth

Von Willebrand syndrome with impressive bleeding history

    • Cases
    • Education
    • Gynecology
    • Hematology
    • RX
  • 3 minute read

A patient who had already suffered four miscarriages related to bleeding complications presents for thrombophilia screening at the 6th week of gestation. During the diagnostic process, Von Willebrand syndrome is detected, which must be taken into account in the course of pregnancy, during delivery and in the puerperium.

Laboratory values
Baseline
(10.12.2018)
23. SSW
(20.03.2019)
29TH SSW
(06.05.2019)
aPTT
26s
25s
24s
FVIII:C
123%
231%
238%
VWF:Ag
106.0%
185.5%
196.8%
VWF:RCo
49.1%
52.8%
60.9%
VWF:CBA
46.0%
53.2%
63.7%
VWF:RCo/VWF:Ag Ratio
0.5
0.3
0.3
Protein S activity
N/A
45.3%
N/A
Free protein S
N/A
51.9%
N/A
D-dimers
N/A
2.27 mg/L
2.67 mg/L
PFA-100
231s/147s
167s/110s
N/A
An overview with gestational age-specific reference intervals can be found in
Szecsi PB et al: Haemostatic reference intervals in pregnancy. Thromb Haemost. 2010;103(4):718-727.
Comment by Rosa Sonja Alesci, MD

Von Willebrand syndrome is significantly underdiagnosed overall, as this case of a 33-year-old female patient also shows. Many sufferers have become accustomed to the symptoms and do not see a doctor. Thus, during thrombophilia screening in the context of habitual abortions, it is not uncommon for Von Willebrand syndrome to be diagnosed as an incidental finding. In the present case, especially in view of the four previous miscarriages with hemorrhage and the very impressive bleeding history, replacement of Von Willebrand factor during pregnancy was essential. In addition, the patient had to be closely monitored, especially at the beginning, since was also known to have thrombophilia. This made it possible to respond to individual circumstances and to react quickly to conspicuous complications. Overall, the present case demonstrates that recombinant Von Willebrand factor (Veyvondi®) can be successfully used in a rare type of Von Willebrand syndrome. After a history of four miscarriages, the vaginal bleeding during pregnancy was optimally treated and the birth was also without complications. No thrombotic side effects occurred and Veyvondi® could also be administered without problems in the puerperium.

See also current technical information VEYVONDI® www.swissmedicinfo.ch

Abbreviations

aPTT = activated partial thromboplastin time; FVIII:C = factor VIII activity; GI = gastrointestinal; IU = international unit; PFA-100 = Platelet Function Analyzer 100; VWF:Ag = von Willebrand factor antigen; VWF:CBA = von Willebrand factor collagen binding activity; VWF:RCo = von Willebrand factor ristocetin cofactor activity; CNS = central nervous system.

C-APROM/CH//0782  07/2020 


VEYVONDI

®

Brief technical information

Z: Active ingredient: Vonicogum alfa. I: Treatment of hemorrhage or bleeding due to surgery in the from–Willebrand–disease when therapy with desmopressin (DDAVP) alone is ineffective or contraindicated. D: Dosage and frequency must be individualized based on clinical judgment and based on patient weight, type and severity of bleeding episodes/surgical intervention, and based on monitoring of appropriate clinical and laboratory measurements; Intravenous administration. AI: Hypersensitivity to the active substance or any of the excipients. Known allergic reaction to mouse– or hamster proteins.
VM:
There are hypersensitivity– or allergic reactions occurred, which may progress to severe anaphylaxis. Monitor patients closely during infusion. Neutralizing antibodies can be formed against Von–Willebrand–Develop factor. There is a risk of thrombotic events. SS: Use only with clear indication. UW: From–Willebrand–Factor Inhibitors, Hypersensitivity– or allergic reactions, tremor, hypertension, vertigo, deep vein thrombosis, ECG changes. IA: There are no known interactions. P: Lyophilisate with 650 I.U. or 1,300 I.U. with 5 ml (resp. 10 ml for 1,300 I.E.) water for injection. Levy category B. Z: Takeda Pharma AG, 8152 Opfikon. You can find detailed information at www.swissmedicinfo.ch

Partner
  • takeda_neu_4
Autoren
  • Dr. med. Rosa Sonja Alesci
Related Topics
  • veyvondi
  • Willebrand syndrome.
Previous Article
  • Bladder Cancer

Immunotherapy after chemo may prolong survival

  • Congress Reports
  • Oncology
  • RX
  • Studies
  • Urology
View Post
Next Article
  • Diabetic kidney disease

Canagliflozin approved in fast track for diabetic nephropathy

  • Endocrinology and Diabetology
  • General Internal Medicine
  • Market & Medicine
  • Nephrology
  • Partner Content
  • RX
View Post
You May Also Like
View Post
  • 7 min
  • Atopic dermatitis and allergies Atopic dermatitis and allergies

Type 2 inflammation and other factors

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Congress Reports
    • RX
    • RX
    • Studies
    • Studies
View Post
  • 5 min
  • Idiopathic cholestasis

Genotype-phenotype correlations in PFIC

    • Congress Reports
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Genetics
    • RX
    • Studies
View Post
  • 6 min
  • Prevalence, pathogenesis and individual treatment strategies

Epilepsy in multiple sclerosis

    • Education
    • Neurology
    • RX
    • Studies
View Post
  • 3 min
  • From symptom to diagnosis

X-ray images Dyspnea – funnel chest

    • Cases
    • Education
    • General Internal Medicine
    • Orthopedics
    • Radiology
    • RX
    • Surgery
View Post
  • 13 min
  • Focus on prevention

Colorectal cancer screening – an update

    • CME continuing education
    • Gastroenterology and Hepatology
    • Oncology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 0 min
  • Lung cancer

Multidisciplinary teams in oncology

    • CME continuing education
    • General Internal Medicine
    • Neurology
    • Nuclear Medicine
    • Oncology
    • Pneumology
    • Prevention and health care
    • RX
    • Studies
    • Surgery
    • Urology
View Post
  • 6 min
  • Early detection of psoriatic arthritis (PsA)

“Hot Topic” – intervene in good time!

    • Congress Reports
    • Dermatology and venereology
    • General Internal Medicine
    • Rheumatology
    • RX
    • Studies
View Post
  • 4 min
  • Obesity

Extent of weight reduction is prognostically relevant

    • Congress Reports
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Multidisciplinary teams in oncology
  • 2
    Colorectal cancer screening – an update
  • 3
    Constant dripping – alcohol and cancer
  • 4
    Hurdles to pain treatment for autistic patients
  • 5
    Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.